TrialCancer medicine2023

Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II study.

Xichao Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.